Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis
PURPOSE: Observations studies have shown that prior use of statins is associated with a reduced risk of adverse clinical outcomes in patients with COVID-19. However, the available data are limited, inconsistent and conflicting. Besides, no randomised controlled trial exists in this regard. Hence, th...
Main Authors: | Banerjee, M. (Author), Bhattacharjee, S. (Author), Pal, R. (Author), Yadav, U. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis
by: Amir Vahedian-Azimi, et al.
Published: (2021-01-01) -
Statin Drug Therapy May Increase COVID-19 Infection
by: Sanjaya Kumar Shrestha
Published: (2020-03-01) -
Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
by: Chiara Citterio, et al.
Published: (2021-06-01) -
Coronavirus: Update Related to the Current Outbreak of COVID-19
by: Giovanni Gabutti, et al.
Published: (2020-04-01) -
The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis
by: Wafa Dhouib, et al.
Published: (2021-04-01)